TipRanks
Purple Biotech (DE:1YI0)
FRANKFURT:1YI0
Germany Market
1YI0
Purple Biotech
RESEARCH TOOLSreports

Purple Biotech (1YI0) Income Statement

0 Followers

Purple Biotech Income Statement

Last quarter (Q2 2026), Purple Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Purple Biotech's net income was $441.00K. See Purple Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 27.46M$ 11.01M$ 22.27M$ 22.60M$ 17.93M
Depreciation and Amortization
$ 203.00K$ 186.00K$ 197.00K$ 201.00K$ 231.00K
EBITDA
$ -26.25M$ -7.05M$ -19.72M$ -21.49M$ -17.52M
Operating Income
$ -27.46M$ -11.01M$ -22.27M$ -22.60M$ -17.93M
Other Income/Expenses
$ 966.00K$ 3.73M$ 2.29M$ 843.00K$ 108.00K
Pretax Income
$ -26.49M$ -7.28M$ -19.98M$ -21.76M$ -17.83M
Net Income
$ -26.39M$ -7.24M$ -19.88M$ -21.67M$ -18.38M
Per Share Metrics
Basic EPS
$ -5.50$ -4.42$ -17.96$ -24.00$ -20.00
Diluted EPS
$ -5.50$ -4.42$ -17.96$ -24.00$ -20.00
Weighted Average Shares Outstanding
 4.80M 1.64M 1.11M 902.83K 910.18K
Weighted Average Shares Outstanding (Diluted)
 4.80M 1.64M 1.11M 904.05K 878.40K
Currency in USD

Purple Biotech Earnings and Revenue History